Europe

UK Pauses Prescribing Cross-Sex Hormones to Children Following Review

The UK’s national health service launched a 90-day consultation on proposals to permanently remove the treatment as a routine procedure for under-18s.
UK Pauses Prescribing Cross-Sex Hormones to Children Following Review
Dr. Hilary Cass, independent pediatrician, speaks about the publication of the Independent Review of Gender Identity Services for Children and Young People (The Cass Review) in west London, on April 9, 2024. Yui Mok/PA Wire
Rachel Roberts
|Updated:

Prescribing cross-sex hormones to 16 and 17-year-olds has been paused in the UK after a review by national health authorities found that evidence does not support their use.

Masculinizing or feminizing hormones have been available for over a decade for young people aged 16-18 with a diagnosis of gender dysphoria who meet certain criteria, but all new referrals have been paused since March 9.

Rachel Roberts
Rachel Roberts
Author
Rachel Roberts is a London-based journalist with a background in local then national news. She focuses on health and education stories and has a particular interest in vaccines and issues impacting children.